Mechanism_NN
of_IN
antiandrogen_JJ
action_NN
:_:
conformational_JJ
changes_NNS
of_IN
the_DT
receptor_NN
._.

Androgen_NN
receptor_NN
mRNA_NN
was_VBD
translated_VBN
in_FW
vitro_FW
,_,
and_CC
androgen_NN
-_:
and_CC
antiandrogen-bound_JJ
receptor_NN
complexes_NNS
were_VBD
studied_VBN
using_VBG
limited_JJ
proteolytic_JJ
digestion_NN
by_IN
trypsin_NN
._.

Partial_JJ
proteolysis_NN
of_IN
androgen-bound_JJ
receptor_NN
protein_NN
resulted_VBD
in_IN
a_DT
29-kDa_JJ
proteolysis-resisting_JJ
fragment_NN
,_,
whereas_IN
antiandrogen_JJ
binding_NN
stabilised_VBD
a_DT
35-kDa_JJ
fragment_NN
._.

Both_DT
fragments_NNS
contain_VBP
the_DT
entire_JJ
ligand_NN
binding_NN
domain_NN
,_,
and_CC
the_DT
35-kDa_JJ
fragment_NN
extended_VBD
into_IN
the_DT
hinge_NN
region_NN
of_IN
the_DT
receptor_NN
._.

Several_JJ
antiandrogens_NNS
show_VBP
agonistic_JJ
properties_NNS
for_IN
a_DT
mutated_VBN
androgen_NN
receptor_NN
-LRB-_-LRB-
LNCaP_NN
cell_NN
variant_NN
-RRB-_-RRB-
;_:
trypsin_NN
digestion_NN
of_IN
antiandrogen-bound_JJ
mutated_VBN
receptor_NN
also_RB
resulted_VBD
in_IN
a_DT
29-kDa_JJ
fragment_NN
._.

Our_PRP$
results_NNS
point_VBP
to_TO
an_DT
important_JJ
difference_NN
between_IN
antiandrogens_NNS
and_CC
antagonists_NNS
of_IN
other_JJ
steroid_NN
hormone_NN
receptors_NNS
._.

Antiandrogens_NNS
result_VBP
in_IN
protection_NN
of_IN
both_CC
the_DT
hinge_NN
region_NN
and_CC
C-terminus_NN
of_IN
the_DT
androgen_NN
receptor_NN
agonist_NN
proteolytic_JJ
attack_NN
,_,
whereas_IN
other_JJ
studies_NNS
showed_VBD
that_IN
antiestrogens_NNS
and_CC
antiprogestagens_NNS
expose_VBP
the_DT
C-terminal_JJ
end_NN
of_IN
the_DT
ligand_NN
binding_NN
domain_NN
of_IN
their_PRP$
respective_JJ
receptors_NNS
to_TO
protease_NN
._.

Differences_NNS
in_IN
conformation_NN
of_IN
the_DT
hinge_NN
region_NN
distinguish_VBP
androgen-bound_JJ
from_IN
antiandrogen-bound_JJ
receptor_NN
complexes_NNS
,_,
which_WDT
represents_VBZ
an_DT
important_JJ
feature_NN
of_IN
antiandrogen_JJ
action_NN
._.

